| 428 |
351: Increased Mortality |
442: Decreased, Population trajectory |
Nov 29, 2016 |
Dec 20, 2019 |
None
|
| 411 |
228: demethylation, PPARg promoter |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 405 |
348: Malformation, Male reproductive tract |
406: decreased, Fertility |
Nov 29, 2016 |
Dec 2, 2016 |
1 AOP
|
| 683 |
669: Reduction, Neuronal synaptic inhibition |
682: Generation, Amplified excitatory postsynaptic potential (EPSP) |
Nov 29, 2016 |
May 15, 2018 |
1 AOP
|
| 684 |
682: Generation, Amplified excitatory postsynaptic potential (EPSP) |
616: Occurrence, A paroxysmal depolarizing shift |
Nov 29, 2016 |
May 15, 2018 |
1 AOP
|
| 685 |
685: Reduced, Prostaglandins, ovary |
488: Decrease, Ovulation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 686 |
79: Inhibition, Cyclooxygenase activity |
685: Reduced, Prostaglandins, ovary |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 687 |
488: Decrease, Ovulation |
675: Reduced, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 689 |
79: Inhibition, Cyclooxygenase activity |
687: Reduced, Prostaglandin E2 concentration, hypothalamus |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 690 |
687: Reduced, Prostaglandin E2 concentration, hypothalamus |
689: Reduced, Gonadotropin releasing hormone, hypothalamus |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 691 |
689: Reduced, Gonadotropin releasing hormone, hypothalamus |
690: Reduced, Luteinizing hormone (LH), plasma |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 692 |
690: Reduced, Luteinizing hormone (LH), plasma |
691: Reduced, Maturation inducing steroid, plasma |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 693 |
691: Reduced, Maturation inducing steroid, plasma |
692: Reduced, Maturation inducing steroid receptor signalling, oocyte |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 694 |
692: Reduced, Maturation inducing steroid receptor signalling, oocyte |
693: Increased, cyclic adenosine monophosphate |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 695 |
693: Increased, cyclic adenosine monophosphate |
675: Reduced, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 696 |
693: Increased, cyclic adenosine monophosphate |
694: Reduced, Meiotic prophase I/metaphase I transition, oocyte |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 697 |
694: Reduced, Meiotic prophase I/metaphase I transition, oocyte |
675: Reduced, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 698 |
692: Reduced, Maturation inducing steroid receptor signalling, oocyte |
695: Upregulated, Spindle assembly checkpoint protein Mad2-oocyte |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 699 |
695: Upregulated, Spindle assembly checkpoint protein Mad2-oocyte |
696: Increased, Chromosome misseggregation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 700 |
696: Increased, Chromosome misseggregation |
675: Reduced, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 701 |
697: impaired, ion channels |
698: Altered, Action Potential |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 702 |
698: Altered, Action Potential |
699: Increased, cardiac arrthymia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 703 |
699: Increased, cardiac arrthymia |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 452 |
12: AchE Inhibition |
351: Increased Mortality |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 453 |
12: AchE Inhibition |
442: Decreased, Population trajectory |
Nov 29, 2016 |
Dec 20, 2019 |
None
|